Autonomix Medical (AMIX) Projected to Post Quarterly Earnings on Thursday

Autonomix Medical (NASDAQ:AMIX) will likely be issuing its results before the market opens on Thursday, June 4th. Analysts expect the company to announce earnings of ($0.26) per share for the quarter.

Autonomix Medical (NASDAQ:AMIX) last posted its quarterly earnings results on Wednesday, May 27th. The company reported $0.09 EPS for the quarter.

Autonomix Medical Stock Performance

NASDAQ:AMIX opened at $0.42 on Thursday. Autonomix Medical has a one year low of $0.20 and a one year high of $2.64. The stock has a market cap of $2.88 million, a PE ratio of -0.12 and a beta of -1.82. The stock has a 50 day moving average price of $0.38 and a 200 day moving average price of $0.52.

Wall Street Analyst Weigh In

AMIX has been the subject of several recent research reports. Maxim Group cut their price target on Autonomix Medical from $5.00 to $2.00 and set a “buy” rating for the company in a report on Tuesday, February 17th. Weiss Ratings raised Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a report on Monday, May 18th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $2.00.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.